PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Testing parents' patience, while treating kids' problem behavior

Delay discounting in parental decision-making

2014-10-14
(Press-News.org) Humans have a focus on the short term. We are more interested in a potential benefit if we can get it now.

The ability to delay gratification has been studied in children with the "marshmallow test": a child can have one treat now, or two if he or she can wait a few minutes without gobbling the first treat.

Psychologists and economists have shown that similar trends can be observed and measured in many spheres of life. They call the tendency for the perceived value of a delayed benefit to diminish "delay discounting."

Now researchers at Marcus Autism Center are studying delay discounting as it applies to parents' decision-making, when it comes to engaging in treatment for their children's problem behavior.

Their initial report is published in Journal of Autism and Developmental Disorders.

Lead author Nathan Call, PhD, director of Severe Behavior Programs at Marcus Autism Center, Children's Healthcare of Atlanta and assistant professor of pediatrics at Emory University School of Medicine, says his team's work is aimed at designing treatment programs that families can stick to, and helping them do so.

Call's co-authors were biostatisticians Scott Gillespie and Courtney McCracken, PhD in the Department of Pediatrics, Mindy Scheithauer at Marcus Autism Center, and Andrea Reavis, now at Trumpet Behavioral Health.

Effective behavioral treatments for children displaying problem behaviors exist, but immediate success is not guaranteed. On the part of parents, they require commitment, active adherence and work.

"It is not unusual for treatments for such severe problem behavior to require implementation by caregivers for 6 months or more to achieve positive outcomes," the authors write.

"Here's the frustrating moment for me as a clinician," Call says. "It's my job to meet with parents, and develop strategies and programs that we think will work. At the start, parents are committed. If you ask them to say how important is it to you to address these problems, on a scale from 1 to 10, they will say '11', but within a couple months, some parents decide, 'We're not going to do this.' "

Call says that in response to signs of delay discounting, clinicians may be able to modify treatment programs to emphasize smaller, but more immediate treatment successes, or assign additional support resources if necessary.

In the new paper, Call and his team gave 17 parents a series of choices, one set based on monetary rewards and another set based on treatment for their child's behavior. The childrens' most common diagnosis was autism spectrum disorder, and the most common problem behaviors were aggression, disruptive behavior and self-injury.

In the test for monetary rewards, the choice was between $1000 after a delay, or a lesser amount immediately. Similarly, parents were offered a hypothetical treatment program that would stop their child's problem behavior. They could choose between a program that would be effective for 10 years and would start after a delay, and a program whose benefits would start right away but would last for less time.

"The value these participants placed upon the outcome of a treatment for their child's problem behavior consistently decreased the longer that outcome took to be achieved," the authors write.

To be sure, when treatment to reduce problem behavior works, the effects are gradual, frequently incomplete, and it is difficult to predict the degree of success with certainty. Call says his team's follow-up studies are taking these uncertainties into account. Additional research could examine whether delay discounting tends to vary according to the age of the child or other family factors.

"We're not surprised delay discounting appears in the realm of parental decision-making," he says. "Clinicians know this is a problem. But I think if we can measure it, we can possibly predict it or change it. Because so much is known about delay discounting in other areas, we can capitalize on that knowledge and use it to help us translate our findings into best practices."

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

NASA satellite spots Hudhud's remnants

NASA satellite spots Hudhuds remnants
2014-10-14
Cyclone Hudhud made landfall in east-central India on Oct. 12 and caused a lot of damage and several fatalities as it moved inland and weakened to a remnant low pressure area. NASA saw those remnants on Oct. 14. When NASA's Aqua satellite passed over Indochina, the Moderate Resolution Imaging Spectroradiometer or MODIS instrument provided picture proof that the remnants of Typhoon Hudhud were still over India, Nepal, and China. Aqua passed over the region on Oct. 14 at 08:05 UTC (4:05 a.m. EDT). Infrared satellite imagery and multispectral satellite imagery indicated ...

EMA open to discuss use of complementary methodologies for rare cancers

2014-10-14
On 3 October 2014, the European Medicines Agency (EMA) hosted a meeting with representatives of Rare Cancers Europe (RCE) to discuss RCE's recent publication of a consensus paper on the methodology of clinical trials in rare cancers (1). Rare Cancers Europe (RCE) is a multi stakeholder initiative promoted by ESMO (representing healthcare professionals, patients and industry) dedicated to putting rare cancers on the European political agenda. In their consensus document, RCE argue that a higher degree of uncertainty should be accepted for regulatory as well as clinically ...

New information about how neurons act could lead to brain disorder advancements

New information about how neurons act could lead to brain disorder advancements
2014-10-14
COLUMBIA, Mo. – Neurons are electrically charged cells, located in the nervous system, that interpret and transmit information using electrical and chemical signals. Now, researchers at the University of Missouri have determined that individual neurons can react differently to electrical signals at the molecular level and in different ways—even among neurons of the same type. This variability may be important in discovering underlying problems associated with brain disorders and neural diseases such as epilepsy. "Genetic mutations found in neurological disorders ...

Orphanage care linked to thinner brain tissue in regions related to ADHD

Orphanage care linked to thinner brain tissue in regions related to ADHD
2014-10-14
Under the rule of dictator Nicolae Ceausescu, thousands of Romanian children were placed in overcrowded orphanages with bleak conditions and minimal human contact. Even after the 1989 revolution, the legacy of institutionalization continued. Only recently has research and public concern over early childhood environments caused changes in policies. University of Washington research on children who began life in these institutions shows that early childhood neglect is associated with changes in brain structure. A paper published this month in Biological Psychiatry shows ...

Corruption of the health care delivery system

2014-10-14
LEBANON, NH – The foundation of evidence-based research has eroded and the trend must be reversed so patients and clinicians can make wise shared decisions about their health, say Dartmouth researchers in the journal Circulation: Cardiovascular Quality and Outcomes. Drs. Glyn Elwyn and Elliott Fisher of The Dartmouth Institute for Health Policy & Clinical Practice are authors of the report in which they highlight five major problems set against a backdrop of "obvious corruption." There is a dearth of transparent research and a low quality of evidence synthesis. ...

Personalised treatment for stress-related diabetes

2014-10-14
Researchers at Lund University in Sweden are testing a treatment for type 2 diabetes which targets the disease mechanism itself - and not just the symptoms. For the first time, knowledge about the individual patient's genetic risk profile is being used. The treatment completely restores the capacity to secrete insulin, which is impaired by the risk gene. "The concept of treatment personalised to the individual's risk profile has great potential. Our results show that it is possible to block the effects of a common risk gene for type 2 diabetes", says Anders Rosengren, ...

Are there enough fish to go around?

2014-10-14
Scientists from the University of York have released a report highlighting the gap between declining wild fish supplies and healthy eating advice recommending more seafood. While the health benefits of eating fish have become better appreciated in recent years, many wild fish stocks continue to be overfished. In a study published in Marine Pollution Bulletin, Dr Ruth Thurstan, now a Research Fellow at the University of Queensland, and Professor Callum Roberts, Professor of Marine Conservation at the University of York, used historical fisheries data and population ...

Immune cells in the liver drive fatty liver disease and liver cancer

2014-10-14
The results of their research have been published as the cover story of the renowned medical journal Cancer Cell. Fatty liver disease – alongside fatty liver due to massive alcohol consumption – is mainly caused by excessive consumption of fat and sugar combined with a lack of exercise or a sedentary life style. This is referred to as non-alcoholic fatty liver disease (NAFLD). If NAFLD becomes chronic – e.g. through the constant uptake of high lipids and high sugar combined with lack of excercise a chronic inflammatory response is triggered in the liver ...

Parkinson: How toxic proteins stress nerve cells

2014-10-14
This news release is available in German. FRANKFURT Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells. A team or researchers led by Frankfurt neurophysiologists has now defined how this selective disease process begins using ...

Researchers identify potential drug that could help treat cystic fibrosis

2014-10-14
From an early age, the lungs of individuals with cystic fibrosis (CF) are colonised and infected by bacteria, a common example being S. aureus. These bacterial infections cause the lungs to become inflamed, infected, and can eventually lead to permanent lung damage. Researchers from the University of Pennsylvania and the Howard Hughes Medical Institute previously showed that an enzyme called Sphingomyelin phosphodiesterase C (SMaseC) produced by the S. aureus bacterium may harm the health of CF patients. Now, they have discovered an inhibitor for this pathogenic bacterial ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Testing parents' patience, while treating kids' problem behavior
Delay discounting in parental decision-making